baber/WOPTO huggingface dataset:
Patent CA-2657297-A1 (CA)
Inventor: LERMER ROLAND
IPC: A23L19/00
Filed: 2006-07-12
Abstract: A dehydrated slice of a vegetable or a fruit is provided, which is adapted to be rehydrated by a rehydration process, having a circumference which is substantially the same as the circumference of the respective slice of the raw vegetable, and having a thickness which is reduced about 20 to 90 % in comparison to the thickness of the respective slice of the raw vegetable or fruit. The dehydrated slice has a planar surface. Furthermore, a method is provided to produce said dehydrated slices. Said dehydrated slices are adapted to be rehydrated by a rehydration process herein provided, whereby performance of said process leads to a rehydrated slice with a thickness of the respective raw vegetable or fruit.
Patent CA-2657422-A1 (CA)
Title: Combinations of biological control agents with a nematicidal seed coating
Inventor: BECKER JORN OLE
IPC: A01N63/30
Filed: 2007-06-18
Abstract: This invention provides combinations of at least one biological control agent and at least one nematicide to enhance plant protection against pests and pathogens.
Patent CA-2657491-A1 (CA)
Title: Vaccines
Inventor: DALTON COLIN CLIVE
IPC: A61K39/00
Filed: 2001-07-18
Abstract: The present invention relates to efficient devices for administration of pharmaceutical agents into the skin of the human body. In particular the present invention provides devices for vaccination into the skin. The present invention provides a pharmaceutical agent delivery device having skin-piercing portion comprising a solid reservoir medium containing the pharmaceutical agent, wherein the reservoir medium is coated onto the skin piercing portion.  alternatively, the skin piercing portion may consist of the solid pharmaceutical agent reservoir medium. The pharmaceutical delivery devices are proportioned such that agent is delivered into defined layers of the skin, and preferred delivery devices comprise skin-piercing portions that deliver the pharmaceutical agent into the epithelium or the dermis. Preferred reservoir media comprise sugars, and in particular stabilising sugars that forms a glass such as lactose, raffinose, trehalose or sucrose. Furthermore, vaccine delivery devices for administration of vaccines into the skin are provided, methods of their manufacture, and their use in medicine.
Patent CA-2658714-A1 (CA)
Title: Hcv-derived polypeptides and uses thereof
Inventor: KREY THOMAS
IPC: C12N15/51
Filed: 2009-03-17
Abstract: The present invention relates to Hepatitis C virus (HCV)-derived polypeptides and nucleic acid molecules encoding same which advantageously comprises a cd81--binding region. In this connection, the present invention specifically relates to the use of the polypeptides or nucleic acid molecules in compositions and methods for the prevention, the treatment and the diagnosis of HCV infections.
Patent CA-2659599-A1 (CA)
Title: Amino alcohol derivative and immunosuppressive agent having same as an active ingredient
Inventor: KURIYAMA KAZUHIKO
IPC: A61K45/00
Filed: 2007-08-07
Abstract: Disclosed is an aminoalcohol derivative which is useful as an excellent immunosuppressant. Specifically disclosed is an aminoalcohol derivative represented by the general formula (1) below, which is a highly safe compound having excellent immune suppressing activity.
Patent CA-2659898-A1 (CA)
Title: Method and device for determining and presenting surface charge and dipole densities on cardiac walls
Inventor: SCHARF CHRISTOPH
IPC: A61B5/363
Filed: 2007-08-03
Abstract: The invention discloses a method, a system, a computer program and a device for determining the surface charge and/or dipole densities on heart walls in order to locate the origin(s) of cardiac arrhythmias.
Patent CA-2660262-A1 (CA)
Inventor: SCHLACK JOHN
IPC: H04N7/025
Filed: 2009-03-27
Abstract: Un système vidéo numérique commuté (SDV) comprend un gestionnaire du SDV pour coordonner des séances SDV demandées par les terminaux d'abonnés associés à au moins un groupe de services. Le système SDV comprend également une entrée pour recevoir du contenu à envoyer pendant les séances SDV et au moins un dispositif de périphérie pour recevoir des flux de transport qui incluent un programme de SDV fourni par la saisie et pour transmettre chaque flux de transport à un réseau d'accès à au moins un des terminaux d'abonnés sur un d'une pluralité de canaux de SDV. En réponse à la réception d'un message provenant d'un terminal d'abonné dans un premier groupe de service indiquant qu'un évènement EAS se produit, le gestionnaire de SDV est configuré pour suspendre la récupération des ressources du réseau allouées au premier groupe de service qui se produit autrement lorsque les terminaux d'abonnés ferment un canal de SDV.
Patent CA-2661804-A1 (CA)
Title: Stent valves and uses of same
Inventor: THORPE PATRICIA E
IPC: A61F2/86
Filed: 2001-01-31
Abstract: The invention includes a medical device and more specifically relates to a valve found generally within a frame. In a preferred device, the frame preferably comprises a self-expanding stent frame, and the valve has at least one expandable and contractible pocket member within the stent frame for resisting and permitting fluid flow, respectively.
Patent CA-2662855-A1 (CA)
Title: Method of establishing communication with wireless control devices
Inventor: MIERTA JUSTIN
IPC: H05B37/02
Filed: 2007-08-14
Abstract: The method of the present invention allows a first wireless control device that is operable to communicate on a predetermined one of a plurality of channels to establish communication with a second wireless control device that may be communicating on any of the plurality of channels. A beacon message is first transmitted repeatedly by the wireless control device on the predetermined channel. The second wireless control device listens for the beacon message for a predetermined amount of time on each of the plurality of channels. When the second control device receives the beacon message on the predetermined channel, the second control device begins communicating on the predetermined channel. The second wireless device may begin listening for the beacon message in response to powering up.
Patent CA-2669318-A1 (CA)
Inventor: RHODES DANIEL R
IPC: C12Q1/68
Filed: 2007-11-08
Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to AGTRl and LBP markers for breast cancer.
Patent CA-2669636-A1 (CA)
Inventor: ETTER ROGER G
IPC: C10B57/06
Filed: 2007-11-19
Abstract: Undesirable gas oil components are selectively cracked or coked in a coking vessel by injecting an additive into the vapors of traditional coking processes in the coking vessel prior to fractionation. The additive contains catalyst(s), seeding agent(s), excess reactant(s), quenching agent(s), carrler(s), or any combination thereof to modify reaction kinetics to preferentially crack or coke these undesirable components that typically have a high propensity to coke. Exemplary embodiments of the present invention also provide methods to control the (1) coke crystalline structure and (2) the quantity and quality of volatile combustible materials (VCMs) in the resulting coke. That is, by varying the quantity and quality of the catalyst, seeding agent, and/or excess reactant the process may affect the quality and quantity of the coke produced, particularly with respect to the crystalline structure (or morphology) of the coke and the quantity & quality of the VCMs in the coke.
Patent CA-2670019-A1 (CA)
Title: Methods, systems, and compositions for cancer diagnosis
Inventor: PITOSSI FERNANDO JUAN
IPC: G06F19/00
Filed: 2007-11-15
Abstract: The invention features methods, systems, and compositions for diagnosing non-central nervous system (non-CNS) cancers by detecting changes in gene or protein expression in the CNS, e.g., in cerebrospinal fluid, in brain or spinal cord tissue samples, or in a bodily fluid.
Patent CA-2670519-A1 (CA)
Inventor: SONG XUEDONG
IPC: G01N33/573
Filed: 2007-09-28
Abstract: A lateral flow assay device for detecting the presence or quantity of an enzyme or enzyme inhibitor is provided. The lateral flow assay device utilizes a molecular substrate to facilitate the detection of an enzyme or enzyme inhibitor via detection of the substrate and/or a product formed in an enzyme-catalyzed reaction of the substrate. In one embodiment, for example, upon contacting a molecular substrate, an enzyme catalyzes a reaction with the molecular substrate and forms a product. The lateral flow assay device also includes a detectable substance that may generate a detectable signal for determining the presence or amount of enzyme in a test sample. For example, the detectable substance may be directly or indirectly attached to a specific binding member that has affinity for the product. Following the enzyme catalyzed reaction, the product may bind the detectable substance which may, in turn, generate the detectable signal. The signal exhibited by the substance may then be used to indicate the presence or quantity of an enzyme or enzyme inhibitor within the test sample.
Patent CA-2670623-A1 (CA)
Title: Device for recharging a battery of a portable ionizing-radiation sensor
Inventor: DEMARTINECOURT NICOLAS
IPC: H01R13/24
Filed: 2007-11-14
Abstract: The present invention relates to a device for recharging a battery of a portable ionizing-radiation sensor (1) placed on a recharging base (3). The sensor (1) has, on one or more accessible faces (13), several electrical contact areas (8) connected to the battery for powering said sensor (1). The recharging base (3) includes a device (35) for moving one or more movable contacts (4). The movable contacts (4) are connected to an energy source. The movable contacts (4) are mechanically entered into the body of the recharging base (3) and mechanically protruded from the body of the recharging base (3) via one or more openings (9) made in the body of the recharging base (3). The movable contacts (4) are electrically in contact with the contact areas (8) of the sensor (1) if one or more of the contact areas (8) are positioned opposite the openings (9) when said movable contacts (4) protrude from the recharging base (3). The invention is used for example in the field of X-ray or gamma-ray medical imaging.
Patent CA-2678821-A1 (CA)
Inventor: PRINGLE DOUGLAS
IPC: A61L27/24
Filed: 2008-02-20
Abstract: The disclosure describes implantable medical products, that include dry or partially hydrated biocompatible constructs comprising collagen fibers configured to expand in situ after implantation to frictionally engage a bone tunnel wall to thereby affix the construct in the bone tunnel.
Patent CA-2679774-A1 (CA)
Title: Adjustable underground meter installation
Inventor: FLOYD SCOTT P
IPC: E03B7/09
Filed: 2009-09-22
Abstract: Various embodiments of the present invention provide adjustable pit liners for use in conjunction with pipelines installed underground. The pit liners provide surface access to devices in fluid communication with the pipeline. The adjustability of the pit liners facilitates installation of the pit liners before the final grade surrounding the pit is known. In various embodiments, a tubular structure having an upper section and a lower section is provided, wherein the upper section and the lower section are slideably connected in a telescoping relationship. A locking mechanism is also provided to releaseably lock the overall height of the tubular structure as desired.
Patent CA-2680262-A1 (CA)
Title: Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
Inventor: SHER ROSY
IPC: A61P25/24
Filed: 2008-03-06
Abstract: The present invention relates to a series of substituted dihydro and tetrahydro oxazolopyrimidinones, specifically, to a series of 2-substituted-2,3-dihydro-oxazolo[3,2-a]pyrimidin-7-ones and 2-substituted-2,3,5,6-tetra-hydro-oxazolo[3,2-a]pyrimidin-7-ones of formula (I): Wherein p, n, X, Y, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein. This invention also relates to methods of making these compounds including novel intermediates. The compounds of this invention are modulators of metabotropic glutamate receptors (mGluR), particularly, mGluR2 receptor. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic neurodegenerative conditions, psychoses, convulsions, anxiety, depression, migraine, pain, sleep disorders and emesis.
Patent CA-2682587-A1 (CA)
Title: Water-soluble iron(iii)-carbohydrate derivative complexes, preparation thereof, and medicaments comprising them
Inventor: FUNK FELIX
IPC: C08B31/18
Filed: 2008-05-21
Abstract: Water-soluble iron-carbohydrate derivative complex obtainable from an aqueous iron(III) salt solution and an aqueous solution of the product of the oxidation and subsequent derivatization of one or more maltodextrins with an aqueous hypochlorite solution at alkaline pH, wherein, in the case of use of a maltodextrin whose dextrose equivalent is from 5 to 20 and in the case of use of a mixture of a plurality of maltodextrins, the dextrose equivalent of the mixture is from 5 to 20 and the dextrose equivalent of each individual maltodextrin involved in the mixture is from 2 to 40, and the subsequent derivatization is effected with a suitable reagent, processes for preparing them and medicaments for treatment and prophylaxis of iron deficiency conditions.
Patent CA-2683862-A1 (CA)
Inventor: GENSURE ROBERT C
IPC: A61K38/48
Filed: 2008-04-09
Abstract: Fusion proteins containing active agonist or antagonist fragments of parathyroid hormone (PTH) and parathyroid hormone related peptide (PTHrP) coupled to a collagen- binding domain are presented. The fusion proteins can be used to promote bone growth, to promote hair growth, to prevent cancer metastasis to bone, to promote immune reconstitution with a bone marrow stem cell transplant, to promote mobilization of bone marrow stem cells for collection for autologous stem cell transplant, and to treat renal osteodystrophy. Pharmaceutical agents comprising a collagen-binding polypeptide segment linked to a non-peptidyl PTH/PTHrP receptor agonist or antagonist are also presented.
Patent CA-2684980-A1 (CA)
Title: Mesh - managing data across a distributed set of devices
Inventor: EDELSTEIN NOAH B
IPC: G06F17/00
Filed: 2008-05-01
Abstract: Data files, applications and/or corresponding user interfaces may be accessed at a device that collaborates in a mesh. The mesh may include any number or type of devices that collaborate in a network. Data, applications and/or corresponding user interfaces may be stored within a core object that may be shared over the mesh. Information in the core object may be identified with a corresponding user such that a user may use any collaborating device in the mesh to access the information. In one example, the information is stored remotely from a device used to access the information. A remote source may store the desired information or may determine the storage location of the desired information in the mesh and may further provide the desired information to a corresponding user.
Patent CA-2685263-A1 (CA)
Inventor: MOE MAGNE MATHIAS
IPC: B66D5/02
Filed: 2008-04-24
Abstract: A drawworks (10) comprising a permanent magnet motor (60) mounted inside a drum(40), said permanent magnet motor arranged to drive said drum via a gear system(50), characterised in that said gear system is located at least partially within said drum.
Patent CA-2685777-A1 (CA)
Inventor: NIKOLOV JONIAN
IPC: F02M69/46
Filed: 2008-05-01
Abstract: A liquid fuel injector connected to the fuel line manifold and return line manifold by plastic tubing, standard petrol fittings, or high pressure hosing so aiding ease of installation, each injector having a separate inlet and return line to assist in fuel temperature control. The injectors are designed to assist in keeping the temperature of the fuel as low as possible with the injector coil not being cooled by the fuel, but by ambient air.
Patent CA-2689793-A1 (CA)
Inventor: REVESZ ROBERT N
IPC: B01D39/08
Filed: 2007-02-22
Abstract: A method and apparatus are disclosed that are useful in bench top sample preparation and filtration techniques, including those related to microwave assisted extraction and partial digestion. In one aspect the method includes the steps of positioning a microwave-transparent matrix removal tool in a microwave transparent reaction vessel adding a matrix-based composition to the microwave reaction vessel containing the removal tool, applying microwave radiation to the reaction vessel, the matrix-based composition, and the matrix removal tool, and removing the matrix based composition from the reaction vessel using the matrix removal tool. In another aspect the method includes the steps of positioning a matrix based composition that includes at least some liquid in a filter vessel, and applying a moderate over-pressure to the composition upstream of the filter to accelerate the movement of liquid through the filter.
Patent CA-2690608-A1 (CA)
Inventor: BEHRENS TIMOTHY W
IPC: C12Q1/68
Filed: 2008-05-21
Abstract: A unique set of genetic variations associated with lupus are provided. Also provided are methods for detecting such genetic variations and for assessing risk of developing lupus as well as for diagnosing and treating lupus.
Patent CA-2691158-A1 (CA)
Inventor: MCCALL MICHAEL J
IPC: C08H8/00
Filed: 2008-06-11
Abstract: A method for preparing biomass for slurry processing. The method includes solubilizing the solid material into either a dissolved state or a suspended solid in a liquid phase, and processing the liquid phase to produce chemicals and fuels.
Patent CA-2692244-A1 (CA)
Inventor: BAYON YVES
IPC: A61L31/12
Filed: 2008-06-27
Abstract: Multilayer structures including a porous layer and a non-porous layer having a reinforcement member are useful as dural repair materials.     Multilayer structures including a porous layer and a non-porous layer having a reinforcement member are useful as dural repair materials.
Patent CA-2692592-A1 (CA)
Inventor: VAIDYA NITIN Y
IPC: E21B33/12
Filed: 2008-04-17
Abstract: A downhole tool includes a swellable core, and a coating that encapsulates the swellable core, wherein the coating is made of a material comprising a component soluble in a selected fluid and a component insoluble in the selected fluid. A method for controlling a downhole tool includes disposing a downhole tool in a wellbore, wherein the downhole tool includes a swellable core, and a coating that encapsulates the swellable core, wherein the coating is made of a material comprising a component soluble in a selected fluid and a component insoluble in the selected fluid; and exposing the swellable device to the selected fluid to increase the permeability of the coating to allow the swellable core to swell.
Patent CA-2692775-A1 (CA)
Inventor: KRAFFT GRANT A
IPC: A61P25/28
Filed: 2007-07-12
Abstract: Disclosed are methods of enhancing cognitive impairment in a patient wherein the cognitive impairment is due to ADDL neurotoxicity. The methods employ non-peptidic compounds having a molecular weight of less than 1000 and which can antagonize against formation of neurotoxic ADDLs from A.beta.1-42 monomers.
Patent CA-2695156-A1 (CA)
Inventor: CHEN SHOUJUN
IPC: A61P37/00
Filed: 2008-07-31
Abstract: The invention relates to compounds that are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
Patent CA-2698686-A1 (CA)
Inventor: JANNA SIED W
IPC: H01Q7/02
Filed: 2008-09-05
Abstract: A telemetric system (10, 300) is disclosed. The telemetric system (10, 300) includes a telemetric implant (400, 500), a reader unit (20) adapted to read signals from the telemetric implant (400, 500), and an antenna (12, 212, 312) adapted for connection to the reader unit (20, 320) and to receive signals from the telemetric implant (400, 500). The antenna (12, 212, 312) has a first coil (14, 214, 314), a second coil (16, 216, 316), and a connector (18, 318). The first coil (14, 214, 314) is electrically connected to the second coil (16, 216, 316), and the connector (18, 318) allows for movement of the first and second coils (14, 214, 314, 16, 216, 316) relative to each other. The antenna (12, 212, 312) may be used to send radio-frequency power to the telemetric implant (400, 500) and receives data from the telemetric implant (400, 500).
Patent CA-2701779-A1 (CA)
Inventor: VAUCHEL GUY
IPC: B64F5/00
Filed: 2008-06-20
Abstract: Ce chariot de maintenance (17) pour entrée d'air (9) de nacelle pour turboréacteur d'aéronef, est remarquable en ce qu'il comprend une base (19) et un plateau (23) monté en porte-à-faux sur cette base (19), adapté pour pénétrer sans contact à l'intérieur de ladite entrée d'air (9).
Patent CA-2712634-A1 (CA)
Inventor: GLASS DAVID
IPC: C07K14/50
Filed: 2009-01-26
Abstract: The present invention is directed to methods, kits and compositions for preventing or treating age-related conditions or metabolic disorders. The Klotho fusion polypeptides of the invention include at least a Klotho protein or an active fragment thereof. The Klotho fusion proteins are useful in the treatment and preventionofa variety of age-related conditions and metabolic disorders.
Patent CA-2714118-A1 (CA)
Inventor: MEYER DOMINIQUE
IPC: A61K49/10
Filed: 2009-02-18
Abstract: The invention relates to a process for preparing a liquid pharmaceutical formulation containing a complex of macrocyclic chelate with a lanthanide and a mol/mol amount offree macrocyclic chelate of between 0.002% and 0.4%, advantageously between 0.02% and 0.3% and very advantageously between 0.025% and 0.25%, the macrocyclic chelate advantageously being chosen from DOTA, NOTA, DOTAGA, DO3A, BT-DO3A, HP-DO3A and PCTA, and is preferably DOTA, the said process comprising the following successive steps: b) preparation of a liquid pharmaceutical composition containing, firstly, the complex of macrocyclic chelate with a lanthanide, and, secondly, free macrocyclic chelate and/or free lanthanide; c) measurement in the pharmaceutical formulation obtained in step b) of the concentration of free macrocyclic chelate C chl and/or of free lanthanide C lanl; d)adjustmentof C chl and/or of C lanl so as to obtain C chl = C tchl and C lanl = 0, wherein C t chl is the target concentration of free macrocyclic chelate in the final liquid pharmaceutical formulation.
Patent CA-2714733-A1 (CA)
Inventor: VERGARA PINTO RODRIGO ANDRES
IPC: B60P1/28
Filed: 2010-09-16
Abstract: A folded hopper for a mining truck is disclosed. The floor of the hopper is made of an anti-abrasive material that is folded and of small thickness, which increases its resistance and simplifies manufacturing work, thus bringing about substantial savings of welding and reducing weight, while improving load distribution. The hopper is made of special steels, with its sides, front portion and shield that are folded. Furthermore, the folded hopper only uses large beams on the sides.
Patent CA-2718200-A1 (CA)
Title: Soft handover timing updates
Inventor: OHLSSON JONAS
IPC: H04W56/00
Filed: 2009-02-24
Abstract: In a mobile communications network, drifts in timing of user equipment in soft handover may be accounted for by measuring the offset between the current timing of the user equipment and the first significant path of downlink frames from cells of the active set at first and second instances. Differences in the respective offsets from the first and second instances may be calculated to determine if the drift is unidirectional in time for all cells of the active set. A unidirectional drift in the offsets is indicative of a drift in timing of the user equipment, allowing the current timing to be momentarily unfrozen and updated.